MC1499A1 - Interferon immun humain homogene et procede pour sa preparation - Google Patents

Interferon immun humain homogene et procede pour sa preparation

Info

Publication number
MC1499A1
MC1499A1 MC831624A MC1624A MC1499A1 MC 1499 A1 MC1499 A1 MC 1499A1 MC 831624 A MC831624 A MC 831624A MC 1624 A MC1624 A MC 1624A MC 1499 A1 MC1499 A1 MC 1499A1
Authority
MC
Monaco
Prior art keywords
column
human immune
interferon
immune interferon
eluted
Prior art date
Application number
MC831624A
Other languages
English (en)
French (fr)
Inventor
Stanley Stein
Richard A Wolfe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1499A1 publication Critical patent/MC1499A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC831624A 1982-03-01 1983-02-25 Interferon immun humain homogene et procede pour sa preparation MC1499A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35344282A 1982-03-01 1982-03-01

Publications (1)

Publication Number Publication Date
MC1499A1 true MC1499A1 (fr) 1983-11-17

Family

ID=23389118

Family Applications (1)

Application Number Title Priority Date Filing Date
MC831624A MC1499A1 (fr) 1982-03-01 1983-02-25 Interferon immun humain homogene et procede pour sa preparation

Country Status (19)

Country Link
EP (1) EP0087686A3 (enExample)
JP (1) JPS58159417A (enExample)
KR (1) KR840003422A (enExample)
AU (1) AU1181283A (enExample)
DK (1) DK104283A (enExample)
ES (1) ES8407499A1 (enExample)
FI (1) FI830557L (enExample)
GB (1) GB2119383A (enExample)
GR (1) GR77910B (enExample)
GT (1) GT198301619A (enExample)
IL (1) IL67978A0 (enExample)
MC (1) MC1499A1 (enExample)
MT (1) MTP924B (enExample)
MW (1) MW783A1 (enExample)
NO (1) NO830697L (enExample)
NZ (1) NZ203364A (enExample)
PT (1) PT76310B (enExample)
ZA (1) ZA83768B (enExample)
ZW (1) ZW4683A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
DE3484374D1 (de) * 1983-08-04 1991-05-08 Green Cross Corp Gamma-interferonzusammensetzung.
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
NZ215563A (en) * 1985-03-25 1989-06-28 Schering Corp Interferon composition
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
JPH01501792A (ja) * 1986-03-17 1989-06-22 シェリング・コーポレーション γ型インターフェロンによる癌の治療
IL84170A0 (en) * 1986-10-17 1988-03-31 Interferon Sciences Inc Method for detecting interferon
ATE74517T1 (de) * 1987-01-20 1992-04-15 Schering Corp Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DE102007050165B4 (de) * 2007-10-19 2010-06-17 Stiftung Tierärztliche Hochschule Hannover Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA120527A (en) * 1907-05-18 1909-09-14 James Mccallum Robertson Prepay device for meters
CA120526A (en) * 1909-05-05 1909-09-14 Robert A. Reynolds Internal combustion engine
CA130300A (en) * 1910-08-03 1911-01-03 John W. Ziegler Current wheel
CA154712A (en) * 1914-01-02 1914-03-31 William Francis Fox Photographic process
CA179241A (en) * 1917-03-02 1917-09-11 John Totterdale Container
IN150740B (enExample) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
ZA803943B (en) * 1979-07-31 1981-06-24 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof

Also Published As

Publication number Publication date
IL67978A0 (en) 1983-06-15
JPS58159417A (ja) 1983-09-21
ZW4683A1 (en) 1983-10-19
PT76310A (en) 1983-03-01
KR840003422A (ko) 1984-09-08
DK104283A (da) 1983-09-02
FI830557A0 (fi) 1983-02-18
ES520164A0 (es) 1984-10-01
MW783A1 (en) 1984-09-12
NO830697L (no) 1983-09-02
ZA83768B (en) 1983-10-26
ES8407499A1 (es) 1984-10-01
AU1181283A (en) 1983-09-08
EP0087686A2 (en) 1983-09-07
EP0087686A3 (en) 1985-09-18
MTP924B (en) 1984-05-03
DK104283D0 (da) 1983-02-28
GB8305506D0 (en) 1983-03-30
NZ203364A (en) 1986-07-11
GR77910B (enExample) 1984-09-25
GB2119383A (en) 1983-11-16
FI830557A7 (fi) 1983-09-02
GT198301619A (es) 1984-08-21
FI830557L (fi) 1983-09-02
PT76310B (en) 1986-02-12

Similar Documents

Publication Publication Date Title
AU674306B2 (en) Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
MC1499A1 (fr) Interferon immun humain homogene et procede pour sa preparation
JP2562192B2 (ja) 血清アルブミンの純化方法
MC1300A1 (fr) Proteines purifiees,procede de preparation et compositions pharmaceutiques les contenant
US5196323A (en) Process for preparing and purifying alpha-interferon
JPH0648956A (ja) ヒト免疫不全ウィルス感染・増殖抑制剤
JPS5813397A (ja) 免疫インタ−フエロン及びそのｍＲＮＡの製造方法
JPS58190397A (ja) インターリューキン−２およびその純化方法
US4483849A (en) Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
FR2600341A1 (fr) Procede de purification d'un produit d'expression genetique obtenu par technique d'adn recombinant
EP0683791B1 (fr) Composition aqueuse proteinique, glycoproteine contenue, procede d'obtention et utilisations
US4617378A (en) Purification of biologically active human immune interferon
KR940010024B1 (ko) α-인터페론의 제조 및 정제 방법
EP0353150B1 (fr) IL2 humaine recombinante non glycosylée sous forme réduite, son procédé d'obtention et son application comme médicament
JPS6261040B2 (enExample)
Kenny et al. [64] Purification of human fibroblast interferon produced in the absence of serum by cibacron blue F3GA-agarose and high-performance liquid chromatography
Cachard et al. Enhancement of mouse interferon production by combined treatment of C-243 cells with butyric acid and theophylline
EP0366532B1 (fr) Médicaments contenant une interleukine-2 glycosylée
JPWO1992014832A1 (ja) ヒトｂｃｄｆの精製法
JPH022390A (ja) 新規なヒト顆粒球マクロファージコロニー刺激因子
JPS6130526A (ja) リンパ球増殖因子
JPS63123393A (ja) ヒトインタ−ロイキン−２の製造法
JPS6157521A (ja) 抗原または抗体の精製方法
FR2537993A1 (fr) Procede pour la production de gamma-interferon humain
FR2638969A1 (fr) Procede d'isolement d'interleukine-2

Legal Events

Date Code Title Description
YP Annual fee paid